Spectranetics
- Company typePrivate
- Founded1984
- HeadquartersColorado Springs, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Spectranetics firmographics
Firmographics- Name
- Spectranetics
- Legal name
- The Spectranetics Corporation
- Website
- https://spectranetics.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Acquired
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Spectranetics industry classification
Industry- Product category
- Cardiovascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
- akta.pro secondary industries
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
Keywords
Where Spectranetics is headquartered
LocationHeadquarters
- HQ city
- Colorado Springs
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Spectranetics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of cardiovascular intervention devices including lead extraction tools, laser atherectomy catheters, balloon catheters, and support devices to hospitals and healthcare facilities through Philips Healthcare distribution network.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Spectranetics product offering
Product offeringCore offering
Spectranetics designs, manufactures, and sells laser-based medical devices and disposable catheters used in three cardiovascular therapy areas: lead management and extraction (laser sheaths, locking devices, extraction catheters, occlusion balloons), peripheral vascular intervention (scoring balloons, drug-coated balloons, laser atherectomy catheters, thrombectomy systems), and coronary intervention (excimer laser systems and laser atherectomy catheters). Its products are sold to hospitals, electrophysiology labs, and cardiac catheterization laboratories, primarily through the Philips Healthcare distribution network following the 2017 acquisition.
Product overview
Spectranetics, now part of Philips Healthcare, offers a comprehensive portfolio of medical devices focused on image-guided therapy. The portfolio spans three main solution areas: lead management and extraction devices (including laser sheaths, locking devices, and extraction catheters), peripheral intervention products (scoring balloons, drug-coated balloons, atherectomy catheters, and thrombectomy systems), and coronary intervention solutions. The core technology platforms include excimer laser systems (CVX300, LAS-100) used across multiple applications, and the product lineup integrates with Philips imaging systems for precision-guided procedures.
Differentiator
Problem solved
Functional benefit
Products and services
- CVX300 Cardiovascular Laser System Excimer laser console for cardiovascular interventions including lead extraction and atherectomy procedures, used by hospitals and cath labs as a capital platform driving laser atherectomy catheters and laser sheaths.
- Philips Laser System Model LAS-100 Laser system platform supporting various cardiovascular laser procedures, used in conjunction with Spectranetics atherectomy catheters and laser sheaths.
- ELCA Coronary Laser Atherectomy Catheter Coronary laser atherectomy catheter for ablating calcified lesions and facilitating stent delivery in coronary arteries, available in multiple configurations including 0.9mm and X-80 variants.
- Turbo Family Laser Atherectomy and Guide Catheters (Turbo-Elite, Turbo-Power, Turbo-Booster, Turbo-Tandem) Family of laser atherectomy and guide catheters (Turbo-Elite, Turbo-Power, Turbo-Booster, Turbo-Tandem) for treating peripheral artery lesions, with combined atherectomy and guide catheter variants to streamline peripheral interventions.
- Glidelight Laser Sheath Laser sheath system for lead extraction procedures that combines mechanical and laser energy to free cardiac leads from vascular adhesions, used in electrophysiology labs treating CIED infections and abandoned leads.
- SLS II Laser Sheath Second-generation laser sheath for lead extraction that combines mechanical telescoping sheaths with excimer laser energy for safer, more efficient lead removal.
- Bridge Occlusion Balloon (Bridge / Bridge Plus) Occlusion balloon (with Bridge Prep Kit) used to manage rare but life-threatening superior vena cava (SVC) tears during lead extraction procedures, now upgraded to Bridge Plus.
- LLD Lead Locking Device Device that provides an internal locking mechanism for cardiac lead extraction procedures, stabilizing the lead for safe removal.
- TightRail Rotating Dilator Sheath Family (TightRail, TightRail Mini, TightRail Sub-C) Mechanically rotating dilator sheath family (standard, Mini, and Sub-C variants) for facilitating lead extraction through calcified tissue.
- Quick-Cross Support Catheter Family (Quick-Cross, Quick-Cross Extreme, Quick-Cross Select) Support catheters including Extreme (high-support for challenging lesion crossing) and Select (steerable, variable tip shaping) variants, plus the Quick-Cross Capture guidewire retriever, used for guidewire support and navigation during peripheral vascular interventions.
- QuickCat Extraction Catheter Extraction catheter designed for lead removal procedures in cardiac lead extraction workflows.
- SightRail Dilator Sheath Set Dilator sheath system used during lead extraction procedures to support lead removal.
- TorqMax Lead Management Device Lead management device used during cardiac lead extraction procedures to facilitate lead removal.
- Quick-Access Needle Holder Surgical instrument used during lead extraction procedures.
- VisiSheath Dilator Sheath Dilator sheath with visualization capabilities for lead extraction procedures, supporting direct visualization during lead removal.
- AngioSculpt Scoring Balloon Catheter Family (PTA, PTCA, AngioSculptX Drug-Coated) Scoring balloon catheter family for PTA (peripheral) and PTCA (coronary) interventions, available in RX and OTW configurations, with the AngioSculptX drug-coated variant combining mechanical scoring with drug delivery.
- Stellarex Drug-Coated Angioplasty Balloon Drug-coated angioplasty balloon available in 0.014 and 0.035 inch profiles (0.035 OTW) for peripheral artery disease treatment.
- ThromCat XT Thrombus Removal System Mechanical thrombectomy system for removing thrombus from peripheral vessels.
Companies that use Spectranetics
Customer profileSegments3 records
Ideal customer profiles3 records
Spectranetics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature12 records
Spectranetics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Philips HealthcarecorePhilips acquired Spectranetics Corporation in August 2017 for approximately $2.2 billion, integrating Spectranetics into Philips' Image Guided Therapy business unit. Spectranetics became part of Royal Philips Healthcare, operating under the Philips brand with its products distributed through Philips healthcare channels.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Spectranetics competitors and assessment
Company assessmentEmerging players
- Penumbra, Inc. Penumbra's Indigo thrombectomy system is a direct competitor to Spectranetics' ThromCat XT for peripheral thrombus removal, and the company is expanding from neurovascular into peripheral vascular intervention, overlapping with the same hospital buying centers.
- Asahi Intecc Co., Ltd. Asahi Intecc is a leading guidewire and microcatheter manufacturer that competes with Spectranetics' Quick-Cross support catheter family, particularly in the peripheral vascular intervention segment where its wires are commonly used alongside or instead of Spectranetics' catheter portfolio.
- Edwards Lifesciences Corporation: While primarily known for structural heart (TAVR/surgical valves), Edwards increasingly overlaps with Spectranetics in the interventional cardiology/structural heart space and competes for the same cath-lab and hybrid OR capital where lead extraction and complex PCI procedures are performed.
Direct peers
- Shockwave Medical (Johnson & Johnson): Shockwave's intravascular lithotripsy (IVL) catheters compete with Spectranetics' laser atherectomy for calcium modification in both coronary and peripheral vessels, representing one of the fastest-growing alternative modalities for the same complex lesion indication.
- AngioDynamics, Inc. AngioDynamics competes with Spectranetics in peripheral vascular intervention (angiographic catheters, thrombolytics, and the recently divested mechanical thrombectomy line) and has overlapping relationships with vascular surgeons and interventional radiologists.
- Becton, Dickinson and Company (BD): BD's Lutonix drug-coated balloon competes head-to-head with Spectranetics' Stellarex DCB in the peripheral artery disease market, and BD also offers Rotarex mechanical thrombectomy devices that overlap with Spectranetics' ThromCat XT.
- Cardiovascular Systems, Inc. (CSI / Abbott): CSI's Diamondback 360 orbital atherectomy system is a direct competitor to Spectranetics' Turbo-Elite and Turbo-Power laser atherectomy catheters in the peripheral artery disease treatment market, addressing the same vessel preparation use case in cath labs and office-based labs.
Broad incumbents
- Medtronic plc: Medtronic competes directly with Spectranetics in lead extraction (Evolution mechanical sheaths), coronary intervention (PCI catheters, scoring balloons), and DCB peripheral intervention (IN.PACT), and is the dominant CIED manufacturer whose lead portfolio drives demand for extraction tools.
- Abbott Laboratories: Abbott is a large incumbent in interventional cardiology with overlapping products in coronary intervention (tretto/tri-rail/NC balloons, PressureWire FFR) and peripheral vascular intervention, and competes for cath-lab equipment capital budgets that Spectranetics' CVX300 system also targets.
- Boston Scientific Corporation: Boston Scientific is a broad cardiovascular incumbent that overlaps with Spectranetics in peripheral intervention (Ranger DCB, atherectomy portfolio), coronary intervention (PCI catheters), and structural heart — competing for the same cath-lab and EP-lab budgets and increasingly bundling imaging-guided solutions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Spectranetics social profiles
Digital presenceSpectranetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Spectranetics leadership team
Management profileNumber of profiles
Profiles1 record
Spectranetics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Spectranetics M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Spectranetics
What does Spectranetics do?
Spectranetics designs, manufactures, and sells laser-based medical devices and disposable catheters used in three cardiovascular therapy areas: lead management and extraction (laser sheaths, locking devices, extraction catheters, occlusion balloons), peripheral vascular intervention (scoring balloons, drug-coated balloons, laser atherectomy catheters, thrombectomy systems), and coronary intervention (excimer laser systems and laser atherectomy catheters). Its products are sold to hospitals, electrophysiology labs, and cardiac catheterization laboratories, primarily through the Philips Healthcare distribution network following the 2017 acquisition.
Is Spectranetics a public or private company?
Spectranetics is a private company. It is classified as corporate owned and is currently acquired.
When was Spectranetics founded?
Spectranetics was founded in 1984. It employs 501 to 1,000 people.
Where is Spectranetics based?
Spectranetics is headquartered in Colorado Springs, United States, in the North America region.
How does Spectranetics make money?
One revenue line is on record: medical Device Sales.
Who are Spectranetics's main competitors?
Emerging players on record are Penumbra, Inc., Asahi Intecc Co., Ltd. and Edwards Lifesciences Corporation. Direct peers are Shockwave Medical (Johnson & Johnson), AngioDynamics, Inc., Becton, Dickinson and Company (BD) and Cardiovascular Systems, Inc. (CSI / Abbott). Broad incumbents are Medtronic plc, Abbott Laboratories and Boston Scientific Corporation.
Does Spectranetics have an API?
No public API is recorded for Spectranetics.
What industry is Spectranetics in?
Spectranetics's product category is Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAKABAB, Interventional Cardiology (PCI/Structural Heart), with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 339112 and its SIC code is 3841.